NIH-funded research R01 grant

How gut bacteria affect rotavirus vaccines in kids

Official title: Intestinal microbiota-mediated rotavirus vaccine failure

Funded at Georgia State University · NIH-11377420 · Data updated 2026-11-12

How the bacteria living in a child’s gut might influence how well oral rotavirus vaccines work.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionGeorgia State University
NIH-funded
Lab location1 site (Atlanta, United States)
Project startSeptember 19, 2022
Project endJuly 31, 2027
Funding year2026
Award (this year)$783,735
NIH project number5R01AI170014-05
Project IDNIH-11377420 on NIH RePORTER

Who could benefit from this research

Could help

Children aged 0-11 years who receive live oral rotavirus vaccines and have gut microbiota profiles that may influence vaccine response.

Less likely to help

Children whose gut microbiota does not interact with vaccine response in the studied way or who do not participate in any sample collection.

What this research studies

This grant explores how the gut microbiome in children affects the effectiveness of attenuated rotavirus vaccines. Researchers will study which gut bacteria and their byproducts alter vaccine replication and gut lining interactions, using human samples and gut culture systems. The goal is to uncover specific microbiota components that drive vaccine failure and to understand the mechanisms behind this effect. Findings could guide new strategies to improve vaccine responses, especially in settings with different gut microbiomes. The work is anchored in human-relevant biology and aims to translate into better protection for children receiving the vaccine.

Why it matters

Potential benefit: Potentially smarter vaccine strategies or adjuncts that boost vaccine efficacy in children.

How similar studies have gone: Prior studies suggest microbiota can affect viral vaccines, indicating this approach has potential but is still being established.

Where this research is happening

  • Georgia State University
    Atlanta, United States
    Active

Researchers

  • Principal investigator: Gewirtz, Andrew T — Georgia State University
  • Study coordinator: Gewirtz, Andrew T

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.